| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2019↕ | FY 2017↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.8B | $5.6B | $5.9B | $5.7B | $4.5B | $4.0B | $3.6B | $3.3B |
| Cost of Revenue | $0.2B | $0.2B | $0.3B | $0.3B | $0.2B | $0.2B | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.7B | $1.0B | $1.4B | $1.6B | $1.0B | $0.5B | $0.8B | $0.9B |
| Net Income | $0.4B | $0.6B | $0.9B | $1.1B | $0.6B | $0.4B | $0.8B | $0.5B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2019↕ | FY 2017↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.5B | $19.1B | $18.1B | $17.3B | $14.7B | $13.4B | $10.7B | $8.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.0B | $1.5B | $2.1B | $2.7B | $1.2B | $0.5B | $0.8B | $0.6B |
| Total Liabilities | $13.0B | $11.9B | $11.6B | $11.4B | $9.8B | $9.2B | $7.3B | $5.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $7.5B | $7.2B | $6.5B | $5.9B | $4.9B | $4.2B | $3.4B | $2.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2019↕ | FY 2017↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $1.5B | $1.7B | $1.9B | $1.5B | $1.1B | $0.9B | $1.0B |
| Investing Cash Flow | $-2.9B | $2.0B | $-2.4B | $-1.9B | $-1.1B | $-1.8B | $-0.9B | $-1.3B |
| Capital Expenditures | $3.5B | $3.0B | $2.7B | $2.1B | $1.4B | $2.3B | $1.4B | $1.5B |
| Financing Cash Flow | $0.9B | $0.1B | $0.1B | $1.4B | $0.3B | $0.5B | $0.0B | $0.4B |